petra langerbeins phd, eha 2019 – results of the phase iii double-blind randomised cll12 trial
Published 5 years ago • 171 plays • Length 4:45Download video MP4
Download video MP3
Similar videos
-
2:48
alessandra tedeschi, eha 2019 – ibrutinib for first-line treatment of cll
-
1:01
aplastic anemia: eha highlights
-
0:50
the impact of covd-19 on advocacy networks
-
0:49
novel targets for car-t therapy in mcl
-
1:06:25
mr birads, dr. petra j. lewis - mri online noon conference
-
3:18
core lab team honored
-
13:10
progress report iii - petra papócsi
-
2:33
promising strategies to optimize car-t therapy in all
-
2:39
an update on the cobra trial: pet-response adapted treatment with brentuximab vedotin for hl
-
1:13
sebastian newrzela, phd
-
0:38
clinical trials: dr. pavani ellipeddi | hematology oncology clinic
-
1:14
looking forward to eha 2021
-
2:17
nathan pennell, md, phd | cleveland clinic hematology & oncology
-
1:46
towards a personalized treatment approach for scd
-
2:22
molecular mrd detection in aml
-
0:45
women in pathology co-leader - pilar alcaide, phd
-
1:23
research spotlight | hanjie zhang, phd | scvo2 in dialysis patients | era-edta 2023
-
1:09
how frontline therapy impacts the management of patients with all prior to car-t
-
1:52
ham-wasserman lecture 2015
-
1:16
an update on the gocart initiative: gocart passports & new edition of the ebmt-eha car-t handbook